Yes Sir,
The Company ended the quarter with US$31.2M in cashcomparedto US$19.4M in the prior quarter.BrainChip reported net operating cash outflows of US$5.0Mvs.US$3.4Min the prior period. The Company ended the quarter with US$31.2M in cashcomparedto US$19.4M in the prior quarter.BrainChip reported net operating cash outflows of US$5.0Mvs.US$3.4Min the prior period. Receipts from customers for the quarter were US$0.2M, a decrease of 81% from US$1.1M in Q4-21. Payments to suppliers and employees were up quarter-on-quarter, totalingUS$5.3M (Q4-21: US$4.9M). Thisincrease was primarily driven by increased marketing and branding expenditures;US$0.5M final milestone payment to Socionextfor the production of the Akidadevice(Q4-21 US$1.0M); additional licensing fees andincreased corporate costs resulting from increased shareholder activity.Cash used for operating activities includespayments to BrainChip’s Board of Directors totalingUS$290,000 as noted in item 6.1 of the accompanying Appendix 4C, comprising directors’ fees for Non-Executive Directors and salariesfor Executive Directors. Net investing cash outflows for the quarter were US$0.07M (Q4-21: US$0.3M), primarily related to new equipment beinginstalled in the new office in California, USA.Payments to suppliers and employees were up quarter-on-quarter, totalingUS$5.3M (Q4-21: US$4.9M). Thisincrease was primarily driven by increased marketing and branding expenditures;US$0.5M final milestone payment to Socionextfor the production of the Akidadevice(Q4-21 US$1.0M); additional licensing fees andincreased corporate costs resulting from increased shareholder activity.Cash used for operating activities includespayments to BrainChip’s Board of Directors totalingUS$290,000 as noted in item 6.1 of the accompanying Appendix 4C, comprising directors’ fees for Non-Executive Directors and salariesfor Executive Directors. Net investing cash outflows for the quarter were US$0.07M (Q4-21: US$0.3M), primarily related to new equipment beinginstalled in the new office in California, USA.
- Forums
- ASX - By Stock
- BRN
- Why I've sold all my BRN... and all my other Stocks
Why I've sold all my BRN... and all my other Stocks, page-1167
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $493.1M |
Open | High | Low | Value | Volume |
26.0¢ | 26.3¢ | 25.0¢ | $2.229M | 8.755M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 777039 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 884503 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 762309 | 0.255 |
42 | 1576175 | 0.250 |
32 | 1117876 | 0.245 |
34 | 1227371 | 0.240 |
20 | 961815 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 884503 | 28 |
0.265 | 528237 | 22 |
0.270 | 599381 | 20 |
0.275 | 760352 | 16 |
0.280 | 712626 | 17 |
Last trade - 13.40pm 18/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online